헬스케어 CRO(임상시험수탁기관) 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Healthcare Contract Research Organization Market size is expected to reach USD 101.36 Billion in 2034 from USD 52.56 Billion (2025) growing at a CAGR of 7.57% during 2026-2034.

The global healthcare contract research organization (CRO) market is expanding rapidly as pharmaceutical and biotechnology companies increasingly outsource research and development activities. CROs provide a wide range of services including clinical trials, regulatory support, data management, and laboratory testing. Outsourcing these activities helps companies reduce operational costs, accelerate drug development timelines, and focus on core competencies.

One of the primary drivers of this market is the growing complexity of clinical trials and regulatory requirements. Pharmaceutical companies are partnering with CROs to access specialized expertise, advanced technologies, and global research networks. Additionally, the increasing number of drug development programs and the rising demand for innovative therapies are further driving the need for contract research services.

Looking forward, the healthcare CRO market is expected to witness strong growth due to the continuous expansion of the pharmaceutical and biotechnology sectors. Technological advancements such as decentralized clinical trials, digital data collection, and artificial intelligence-driven analytics are transforming research operations. Emerging markets in Asia-Pacific are expected to play a key role in market expansion due to cost advantages and growing clinical research capabilities.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Drug Discovery (Target Validation, Lead Identification, Lead Optimization)
• Pre-Clinical
• Clinical (Phase I Trial Services, Phase II Trial Services, Phase III Trial Services, Phase IV Trial Services)

By Service

• Project Management/Clinical Supply Management
• Data Management
• Regulatory/Medical Affairs
• Medical Writing
• Clinical Monitoring
• Quality Management/ Assurance
• Bio-statistics
• Investigator Payments
• Laboratory
• Patient And Site Recruitment
• Technology
• Others

By Therapeutic Area

• Oncology
• CNS Disorders
• Infectious Diseases
• Immunological Disorders
• Cardiovascular Diseases
• Respiratory Diseases
• Diabetes
• Ophthalmology
• Pain Management
• Others

By Molecule

• Pharmaceutical

COMPANIES PROFILED

• LabCorp, Iqvia Inc, Thermo Fisher Scientific, Icon Plc, Syneos Health, Charles River Laboratories, Parexel International Corporation, WuXi AppTec, Medpace, Sgs Sa, Worldwide Clinical Trials, Pharmaron GmbH, CTI Clinical Trial Consulting, Ergomed, GVK Biosciences Private Limited Aragen
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Drug Discovery (Target Validation, Lead Identification, Lead Optimization) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Pre-Clinical Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Clinical (Phase I Trial Services, Phase II Trial Services, Phase III Trial Services, Phase IV Trial Services) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: BY SERVICE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Service
• 5.2. Project Management/Clinical Supply Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Data Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Regulatory/Medical Affairs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Medical Writing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Clinical Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Quality Management/ Assurance Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Bio-statistics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Investigator Payments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.10. Laboratory Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.11. Patient And Site Recruitment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.12. Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.13. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: BY THERAPEUTIC AREA 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Therapeutic Area
• 6.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. CNS Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Immunological Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Cardiovascular Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Respiratory Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.9. Ophthalmology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.10. Pain Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.11. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: BY MOLECULE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Molecule
• 7.2. Pharmaceutical Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Type
  • 8.2.2 By Service
  • 8.2.3 By Therapeutic Area
  • 8.2.4 By Molecule
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Type
  • 8.3.2 By Service
  • 8.3.3 By Therapeutic Area
  • 8.3.4 By Molecule
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Type
  • 8.4.2 By Service
  • 8.4.3 By Therapeutic Area
  • 8.4.4 By Molecule
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Type
  • 8.5.2 By Service
  • 8.5.3 By Therapeutic Area
  • 8.5.4 By Molecule
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Type
  • 8.6.2 By Service
  • 8.6.3 By Therapeutic Area
  • 8.6.4 By Molecule
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 LabCorp
  • 10.2.2 Iqvia Inc
  • 10.2.3 Thermo Fisher Scientific
  • 10.2.4 Icon Plc
  • 10.2.5 Syneos Health
  • 10.2.6 Charles River Laboratories
  • 10.2.7 Parexel International Corporation
  • 10.2.8 WuXi AppTec
  • 10.2.9 Medpace
  • 10.2.10 Sgs Sa
  • 10.2.11 Worldwide Clinical Trials
  • 10.2.12 Pharmaron GmbH
  • 10.2.13 CTI Clinical Trial & Consulting
  • 10.2.14 Ergomed
  • 10.2.15 GVK Biosciences Private Limited (Aragen)